United States Antimony Corporation (UAMY) SEC Filings & Earnings Calls
EquiReason read 34 United States Antimony Corporation SEC filings in the last 12 months. Latest: 8-K on 2026-10-02 — United States Antimony Corporation appointed Shawn P. Winkler as permanent CFO effective September 30, 2026, replacing Richard R. Isaak who was terminated without cause; Winkler ha.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
- Market cap
- 458.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 18 Nov, in 25 days
Every filing, read
last 12 months · SECWhat happened, the numbers inside, guidance and risks. The original is one click away.
2 Oct 20268-K · 5.02United States Antimony Corporation appointed Shawn P. Winkler as permanent CFO effective September 30, 2026, replacing Richard R. Isaak who was terminated without cause; Winkler has investment banking and CFO experience.open
Risks flagged
CFO transition is orderly; no disagreements on financials; low risk.
“Mr. Isaak’s termination was not related to the Company’s financial or operating results or to any disagreements or concerns regarding the Company’s financial or reporting practices.” · word for word
2 Oct 20268-K · 5.02United States Antimony Corporation entered into a new employment agreement with CEO Gary C. Evans, effective August 1, 2026, with a three-year term, base salary of $430,000, and change-in-control provisions.open
Risks flagged
CEO retention risk mitigated by new agreement; change-in-control provisions could be costly.
“if a change in control of the Company occurs... the Company will pay to Mr. Evans an amount equal to two times the sum of Mr. Evans’ then-current base salary and target bonus”
25 Aug 20268-K · 7.01USAC reports mining progress at Stibnite Hill: 42 truckloads (576 tons) of high-grade stibnite ore transported in 2026, with daily rate over 2x faster than 2025 campaign. Operational update, not a material contract or financial event.open
Figures in the filing · each found in the filing text
| Ore transported (tons) · Stibnite Hill · 2026 YTD | 576 | |
| Daily ore transport rate (tons/day) · Stibnite Hill · 2026 | 42 | +136% y/y |
| Truckloads transported · Stibnite Hill · 2026 YTD | 42 |
Risks flagged
Operational risks: mining subject to weather, geological conditions, and permitting; reliance on contractors.
“Winter weather halted 2025 campaign in November; forward-looking statements cite operational risks.”
17 Aug 20268-K · 2.02Q2 2026 revenue $7.9M (-25% YoY), gross margin 7% vs 27% prior year, operating loss $7M; antimony price decline drives compression; zeolite revenue +110% YoY; DLA contract backlog $57.3M; cash $41.4M.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $8M | -25% y/y |
| Gross Profit · Q2-2026 | $600000.00 | -79% y/y |
| Gross Margin · Q2-2026 | 7.0% | |
| Operating Loss · Q2-2026 | $7M | |
| Net Income · Q2-2026 | $100000.00 | -50% y/y |
| Cash and Cash Equivalents · 2026-06-30 | $41M | |
| Antimony Revenue · Antimony · Q2-2026 | $6M | -39% y/y |
| Antimony Pounds Sold · Antimony · Q2-2026 | 428,425 | +26% y/y |
| Antimony Average Selling Price per Pound · Antimony · Q2-2026 | $13.70 | -52% y/y |
| Antimony Average Cost per Pound · Antimony · Q2-2026 | $13.34 | -33% y/y |
Guidance
Q3 2026 expected revenue from DLA deliveries: $2.6M; Q4 2026 expected cash flow from DLA deliveries: ~$4M; cumulative DLA orders $57.3M; four grant applications totaling $275M pending.
DLA contract provides near-term revenue visibility; antimony price pressure persists; zeolite growth positive; grant pipeline large but uncertain.
Risks flagged
Antimony price decline severely compressing margins; operating loss despite revenue growth in zeolite.
“Gross margin 7% vs 27% prior year; antimony ASP -52% YoY; operating loss $7M.”
Dependence on DLA contract and grant approvals for future revenue; geopolitical risks in Bolivia supply chain.
“DLA contract $57.3M cumulative; grant requests $275M pending; Bolivia fuel supply issues due to Iranian war.”
High share-based compensation inflating operating expenses.
“SBC $2.9M in Q2; operating expense $7.6M vs $2.8M prior year.”
11 Aug 20268-K · 2.02Q2 2026 revenue $7.9M (down from $10.5M), net income $0.1M, gross margin 7% (down from 27%), antimony pounds sold up 26% but ASP down 52%. Zeolite revenue up 110% YoY. DLA contract shipments starting. Equity issuances $49.1M net proceeds. Wearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $8M | -25% y/y |
| Net income · Q2-2026 | $100000.00 | -50% y/y |
| Gross profit · Q2-2026 | $600000.00 | -79% y/y |
| Gross margin · Q2-2026 | 7.0% | |
| Antimony pounds sold · Antimony · Q2-2026 | 428,425 | +26% y/y |
| Antimony average selling price per pound · Antimony · Q2-2026 | $13.70 | -52% y/y |
| Antimony average cost per pound · Antimony · Q2-2026 | $13.34 | -33% y/y |
| Zeolite revenue · Zeolite · Q2-2026 | $2M | +110% y/y |
| Zeolite tons sold · Zeolite · Q2-2026 | 6,609 | +114% y/y |
| Working capital · 2026-06-30 | $70M | +100% y/y |
Risks flagged
Significant gross margin compression from 27% to 7% due to antimony price decline.
“Gross profit of $0.6 million (7% gross margin), compared to $2.8 million (27% gross margin) in the 2025 quarter.” · word for word
Operating loss of $7.0 million, offset only by unrealized gains from equity investments.
“Operating loss of $7.0 million, including $3.4 million of net non-cash expense items compared to break-even operating results in the 2025 quarter.” · word for word
Dependence on DLA contract for revenue growth; shipments deferred to Q3.
“Because these shipments were formally accepted by the DLA in July 2026, approximately $2.6 million is expected to be recognized as third-quarter 2026 revenue.” · word for word
Heavy reliance on equity issuances for funding; potential dilution.
“Generated $49.1 million of net proceeds from equity issuances during the first six months of 2026.” · word for word
11 Aug 202610-QQ2 2026 results: antimony revenue down 39% YoY on price decline, zeolite revenue up 110% YoY on volume growth.earningsopen
Figures in the filing · each found in the filing text
| Revenue · Q2-2026 | $8M | -25% y/y |
| Net income (loss) · Q2-2026 | $110290.00 | -39% y/y |
| Antimony revenue · Antimony · Q2-2026 | $6M | -39% y/y |
| Antimony gross profit · Antimony · Q2-2026 | $152857.00 | -95% y/y |
| Pounds of antimony sold · Antimony · Q2-2026 | 428,425 | +26% y/y |
| Average sales price per pound (antimony) · Antimony · Q2-2026 | $13.70 | -52% y/y |
| Average cost per pound (antimony) · Antimony · Q2-2026 | $13.34 | -33% y/y |
| Zeolite revenue · Zeolite · Q2-2026 | $2M | +110% y/y |
| Zeolite gross profit · Zeolite · Q2-2026 | $353603.00 | +189% y/y |
| Tons of zeolite sold · Zeolite · Q2-2026 | 6,609 | +114% y/y |
Risks flagged
Antimony price volatility
“Average sales price per pound 13.70 vs 28.32, a decline of 52%”
Operating cash burn
“Net cash used in operating activities was $20.7 million for the six months ended June 30, 2026” · word for word
Inventory build risk
“a $9.6 million increase in inventories as the Company built up its antimony inventory” · word for word
15 May 20268-K · 2.02Revenue $7M (-3% y/y); Net loss $-11M; Gross profit $1M (-54% y/y); Guidance: Full-year 2026 gross revenue guidance of $125 millionearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $7M | -3% y/y |
| Net loss · Q1-2026 | $-11M | |
| Gross profit · Q1-2026 | $1M | -54% y/y |
| Antimony segment revenue · Antimony · Q1-2026 | $6M | -5% y/y |
| Zeolite segment revenue · Zeolite · Q1-2026 | $1M | -9% y/y |
| Antimony pounds sold · Antimony · Q1-2026 | 278,797 | -23% y/y |
| Average antimony price per pound · Antimony · Q1-2026 | $19.92 | +22% y/y |
| Antimony cost per pound sold · Antimony · Q1-2026 | $16.28 | +69% y/y |
| Zeolite tons sold · Zeolite · Q1-2026 | 3,681 | -3% y/y |
| Cash and cash equivalents including Treasury securities · Q1-2026 | $24M |
Guidance
Full-year 2026 gross revenue guidance of $125 million
Reiterated $125M revenue guidance for FY2026 despite Q1 miss, citing expected ramp in H2.
Risks flagged
High cost inflation pressuring margins; gross margin halved to 16%.
“Gross margin 16% vs 34% prior year due to higher labor, factory, and freight costs.”
Significant non-cash losses from stock compensation and investment markdowns.
“Net loss includes $4.8M stock comp and $4.1M unrealized loss on Larvotto equity.”
14 May 202610-QRevenue $7M (-3% y/y); Net income (loss) $-11M; Antimony pounds sold 278,797 (-23% y/y)open
Figures in the filing · each found in the filing text
| Revenue · consolidated · Q1-2026 | $7M | -3% y/y |
| Net income (loss) · consolidated · Q1-2026 | $-11M | |
| Antimony pounds sold · antimony · Q1-2026 | 278,797 | -23% y/y |
| Antimony average sales price per pound · antimony · Q1-2026 | $19.92 | +22% y/y |
| Antimony average cost per pound · antimony · Q1-2026 | $16.28 | +69% y/y |
| Zeolite tons sold · zeolite · Q1-2026 | 3,681 | -3% y/y |
| Zeolite average sales price per ton · zeolite · Q1-2026 | $276.00 | -4% y/y |
| Zeolite average cost per ton · zeolite · Q1-2026 | $303.00 | +26% y/y |
| Cash and cash equivalents · consolidated · 2026-03-31 | $3M | |
| Working capital · consolidated · 2026-03-31 | $35M |
Risks flagged
Cost inflation outpacing pricing power
“Average cost per pound increased 69% while average sales price increased only 22%.”
Negative operating cash flow
“Net cash used in operating activities was $12.1 million for Q1 2026 vs $1.7 million in prior year.” · word for word
Inventory buildup
“Antimony inventory increased from $12.0M at Dec 2025 to $21.7M at Mar 2026.”
Dependence on government grants
“Additional funding subject to future authorization; no assurance of additional funding.”
14 May 20268-K · 2.02Revenue $7M (-3% y/y); Net loss $-11M; Gross profit $1M (-53% y/y); Guidance: Full-year 2026 gross revenue guidance of $125 millionearningsopen
Figures in the filing · each found in the filing text
| Revenue · Q1-2026 | $7M | -3% y/y |
| Net loss · Q1-2026 | $-11M | |
| Gross profit · Q1-2026 | $1M | -53% y/y |
| Antimony segment revenue · Antimony · Q1-2026 | $6M | -5% y/y |
| Zeolite segment revenue · Zeolite · Q1-2026 | $1M | -9% y/y |
| Antimony pounds sold · Antimony · Q1-2026 | 278,797 | -23% y/y |
| Average antimony price per pound · Antimony · Q1-2026 | $19.92 | +22% y/y |
| Antimony cost per pound sold · Antimony · Q1-2026 | $16.28 | +69% y/y |
| Zeolite tons sold · Zeolite · Q1-2026 | 3,681 | -3% y/y |
| Cash and cash equivalents including Treasury securities · Q1-2026 | $24M |
Guidance
Full-year 2026 gross revenue guidance of $125 million
Reiterated $125M revenue guidance for FY2026 despite Q1 miss, citing expected ramp in H2.
Risks flagged
High cost inflation pressuring margins; gross margin halved to 16%.
“Gross margin 16% vs 34% prior year due to higher labor, factory, and freight costs.”
Significant non-cash losses from stock compensation and investment markdowns.
“Net loss includes $4.8M stock comp and $4.1M unrealized loss on Larvotto equity.”
6 May 20268-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Uncertainty around CFO leave duration and financial reporting continuity.
“Duration of leave not determined; interim CFO appointed.”
20 Apr 2026DEF 14AProxy statement for 2026 annual meeting; includes election of directors, proposal to increase authorized shares, and ratification of auditors.open
Figures in the filing · each found in the filing text
| Net Income (Loss) · FY2025 | $-4M |
Risks flagged
Share dilution risk
“Proposal to increase authorized common shares from 250M to 500M could lead to significant dilution if issued.”
Continued net losses
“Net loss widened to $4.3M in 2025 from $1.7M in 2024, indicating ongoing profitability challenges.”
10 Apr 20268-K · 8.01United States Antimony Corp provided an operational update on its Fostung tungsten project, filing a Technical Report Summary; early-stage exploration update.open
Risks flagged
Early-stage exploration project with no guarantee of economic viability or production. No revenue or cash flow from this asset.
“intermediate-stage tungsten exploration asset... The TRS was completed by SRK Consulting (Canada), Inc.”
19 Mar 202610-KAntimony Sales $35M (+219% y/y); Average Antimony Price per Pound $25.12 (+230% y/y); Antimony Pounds Sold 1,408,513 (-4% y/y)open
Figures in the filing · each found in the filing text
| Antimony Sales · Antimony · FY2025 | $35M | +219% y/y |
| Average Antimony Price per Pound · Antimony · FY2025 | $25.12 | +230% y/y |
| Antimony Pounds Sold · Antimony · FY2025 | $1M | -4% y/y |
| Revenue · Antimony · FY2025 | $35M | +219% y/y |
| Net Income · Consolidated · FY2025 | $59M | |
| Adjusted EBITDA · Consolidated · FY2025 | $53M | +13% y/y |
| Cash and Equivalents · Consolidated · FY2025 | $762M | +4% y/y |
19 Mar 20268-K · 2.02Revenue $39M (+163% y/y); Gross Profit $10M (+185% y/y); Gross Margin 25; Guidance: FY2026 gross revenue guidance of $125 millionearningsopen
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $39M | +163% y/y |
| Gross Profit · FY2025 | $10M | +185% y/y |
| Gross Margin · FY2025 | 25.0% | |
| Net Loss · FY2025 | $-4M | |
| Antimony Revenue · Antimony · FY2025 | $35M | +219% y/y |
| Zeolite Revenue · Zeolite · FY2025 | $3M | +14% y/y |
| Cash and Investments · FY2025 | $91M | |
| Antimony Inventory (tons) · Antimony · FY2025 | 465 | +496% y/y |
| Capital Expenditures · FY2025 | $28M | |
| FY2026 Revenue Guidance · FY2026 | $125M |
Guidance
FY2026 gross revenue guidance of $125 million
Reiterated FY2026 revenue guidance of $125M, implying ~218% YoY growth. Management expects margin expansion from in-house mining and expanded smelting capacity.
Risks flagged
Net loss increased due to non-cash charges; operating expenses rose significantly
“Operating expenses were $18.33 million in 2025, which is an increase of $12.47 million compared to the prior year, $6.7 million of which was non-cash charges.” · word for word
Dependence on China export controls and geopolitical tensions for antimony pricing
“With the worldwide embargo of export controls caused by China in the fall of 2024, prices of antimony increased over 400%... antimony remains the 'most critical' mineral due to its requirements in so many military applications” · word for word
10 Feb 20268-K · 7.01Antimony production (Americas) 561,000open
Figures in the filing · each found in the filing text
| Antimony production (Americas) · Americas Gold and Silver · FY2025 | $561000.00 |
Risks flagged
Construction permits not yet obtained; timeline dependent on permitting.
“all the necessary permits, with the exception of the construction permits” · word for word
JV ownership structure (51/49) may lead to governance complexities.
“ownership of the JV is 51% Americas and 49% US Antimony... All major decisions will be decided by a newly formed committee of equal representation” · word for word
29 Jan 20268-K · 7.01First product receipt volume 150; DOE funding request amount $44Mopen
Figures in the filing · each found in the filing text
| First product receipt volume · Antimony · Feb/Mar 2026 | $150.00 | |
| DOE funding request amount · 2026 | $44M |
Risks flagged
Geopolitical risk from Bolivian operations; reliance on DOE/DoW funding approvals.
“project located in the country of Bolivia... request for funding for a program total of $44 million” · word for word
Technology and operational execution risk for new hydromet process at commercial scale.
“new hydrometallurgical (hydromet) processing facility for refining antimony and other critical minerals on a commercial scale” · word for word
20 Jan 20268-K · 7.01Acquisition price $5M; Future capital expenditures $2Mopen
Figures in the filing · each found in the filing text
| Acquisition price · Q1-2026 | $5M | |
| Future capital expenditures · FY2026 | $2M |
Risks flagged
Execution risk on smelter expansion and facility integration
“Smelter expansion on track for February completion; integration of new facility adds complexity.”
Commodity price risk
“Antimony and other critical minerals prices subject to market volatility.”
5 Jan 20268-K · 7.01Revenue $39M (+160% y/y); Revenue guidance $125M; Cash and cash equivalents $18M; Guidance: 2026 revenue guidance of $125M vs ~$39M in 2025 (220% growth)open
Figures in the filing · each found in the filing text
| Revenue · FY2025 | $39M | +160% y/y |
| Revenue guidance · FY2026 | $125M | |
| Cash and cash equivalents · start of 2025 | $18M | |
| Total liquidity · end of 2025 | $90M | +395% y/y |
| Market capitalization · end of 2025 | $703M | +250% y/y |
| Share price · end of 2025 | $5.02 | +182% y/y |
| Equity raised · FY2025 | $107M | |
| DLA contract value · five-year | $245M | |
| Industrial customer contract value · five-year | $107M | |
| First order from DLA · unknown | $10M |
Guidance
2026 revenue guidance of $125M vs ~$39M in 2025 (220% growth)
Provided 2026 revenue guidance of $125M, implying 220% growth from 2025; growth expected from volumes, not pricing; significant contracts in place.
Risks flagged
Heavy reliance on government and industrial contracts for revenue growth; contract execution risk.
“Revenue guidance of $125M for 2026 is heavily dependent on DLA and industrial contracts.”
Significant equity dilution risk: shares outstanding increased 24% in 2025.
“Outstanding shares only increased 24% from the beginning until the end of the year, after raising $106.6 million of additional equity.” · word for word
Operational execution risk: rapid expansion of mining and smelting operations in one year.
“We did this achievement in one year, which is unheard of in an industry that typically takes decades to open and operate mining assets.” · word for word
25 Nov 20258-K · 5.02, 7.01Reported the departure of a director or principal officer (CEO/CFO change); issued a Regulation FD disclosure (forward guidance or material update)open
Risks flagged
Board expansion may signal strategic shift or capital markets activity
“New director with capital markets and M&A background; formation of Finance Committee suggests focus on financial strategy.”
14 Nov 20258-K · 2.02Sales $26M (+182% y/y); Gross margin 28; Net loss $-4M; Guidance: Q4 margin pressure from declining antimony prices; offset by long-term contracts and volume increase.earningsopen
Figures in the filing · each found in the filing text
| Sales · consolidated · 9M-2025 | $26M | +182% y/y |
| Gross margin · consolidated · 9M-2025 | 28.0% | |
| Net loss · consolidated · 9M-2025 | $-4M | |
| Non-cash expenses · consolidated · 9M-2025 | $5M | |
| Antimony inventory · antimony · Q3-2025 | 300,000 | |
| Sales value of inventory · consolidated · Q3-2025 | $9M | |
| October consolidated sales · consolidated · October-2025 | $6M | |
| Q3 consolidated sales · consolidated · Q3-2025 | $9M |
Guidance
Q4 margin pressure from declining antimony prices; offset by long-term contracts and volume increase.
Strong revenue growth and margin improvement in 9M, but Q4 faces margin pressure from declining antimony prices; management optimistic on long-term contracts and volume.
Risks flagged
Declining antimony market price may pressure Q4 gross margins.
“There will be some pressure on our gross margins in the fourth quarter with a declining antimony market price.” · word for word
Net loss of $4.1M despite revenue growth; high non-cash expenses.
“Consolidated net loss was $4.1 million for the first nine months of this year.” · word for word
12 Nov 20258-K · 1.01, 7.01Contract value $107Mopen
Figures in the filing · each found in the filing text
| Contract value · 5-year | $107M |
Risks flagged
Customer wishes to remain anonymous; concentration risk if contract not renewed.
“Customer wishes to remain anonymous; contract has renewal option.”
12 Nov 202510-QUAMY reported Q3 2025 antimony revenue up 439% YoY and gross profit up 679% YoY, driven by a 382% surge in average selling price, and secured a $245M DLA contract.earningsopen
Figures in the filing · each found in the filing text
| Antimony Revenue · Antimony · Q3-2025 | $8M | +439% y/y |
| Antimony Gross Profit · Antimony · Q3-2025 | $2M | +679% y/y |
| Antimony Pounds Sold · Antimony · Q3-2025 | 279,607 | +12% y/y |
| Antimony Average Sales Price Per Pound · Antimony · Q3-2025 | $28.72 | +382% y/y |
| Antimony Average Gross Profit Per Pound · Antimony · Q3-2025 | $7.83 | +599% y/y |
| Zeolite Revenue · Zeolite · Q3-2025 | $671946.00 | -2% y/y |
| Zeolite Gross Profit (Loss) · Zeolite · Q3-2025 | $-25813.00 | +88% y/y |
| Total Revenue · Q3-2025 | $9M | +238% y/y |
| Net Loss · Q3-2025 | $-5M | |
| Antimony Inventory · Antimony · 2025-09-30 | $8M |
Risks flagged
Operating Losses and Negative Cash Flow
“Net loss $(4,780,700) for Q3 2025; Net cash used in operating activities $(6,220,686) for 9M 2025”
Inventory Build and Working Capital Strain
“Antimony inventory increased from $744,550 at Dec 2024 to $7,992,140 at Sep 2025, a $7.2M increase.”
Dependence on Foreign Ore Supply
“The Company continues to purchase antimony ore from foreign sources, with increasing percentage of market prices charged by suppliers.”
Share Dilution from Equity Raises
“Net proceeds of $38.4M from stock offerings in 9M 2025, plus additional $66M in October 2025.”
12 Nov 20258-K · 2.02Revenues $26M (+182% y/y); Gross profit $7M (+219% y/y); Gross margin 28; Guidance: FY2025 revenue $40-43M (narrowed); FY2026 revenue $125M (reiterated)earningsopen
Figures in the filing · each found in the filing text
| Revenues · 9M-2025 | $26M | +182% y/y |
| Gross profit · 9M-2025 | $7M | +219% y/y |
| Gross margin · 9M-2025 | 28.0% | |
| Net loss · 9M-2025 | $-4M | |
| Antimony sales · Antimony · 9M-2025 | $24M | +235% y/y |
| Zeolite sales · Zeolite · 9M-2025 | $3M | +16% y/y |
| Cash and investments · Q3-2025 | $39M | |
| Capital expenditures · 9M-2025 | $16M | |
| Antimony inventory (tons) · Antimony · Q3-2025 | 230 | |
| Antimony inventory value · Antimony · Q3-2025 | $9M |
Guidance
FY2025 revenue $40-43M (narrowed); FY2026 revenue $125M (reiterated)
Narrowed FY2025 guidance to $40-43M; reiterated FY2026 $125M; strong contract pipeline supports growth.
Risks flagged
Net loss of $4.05M due to non-cash share-based compensation; operating expenses increased significantly.
“Net loss $4.05M vs $847K prior year; operating expenses $11.76M (+$8.19M).”
Dependence on international antimony supply; in-house mining still ramping.
“Current antimony inventory all from international third-party suppliers; in-house mining expected to impact Q1 2026.”
30 Oct 20258-K · 7.01Revenue guidance $125M; Guidance: FY2026 revenue guidance raised by $25M to $125Mopen
Figures in the filing · each found in the filing text
| Revenue guidance · FY2026 | $125M |
Guidance
FY2026 revenue guidance raised by $25M to $125M
Significant guidance raise driven by new antimony mining and international supply; CEO calls it a 'game changer'; margin expansion expected from vertical integration.
Risks flagged
Operational risk from weather-dependent mining; operations to cease in winter and resume in spring
“Operations on the mountain will temporarily cease when weather conditions dictate but will resume again in the spring” · word for word
Reliance on bulk sampling program success; metallurgical test work ongoing
“Anticipating a successful outcome of the bulk sampling program; metallurgical test work to ensure material can be used in full product line is ongoing” · word for word
United States Antimony Corporation — questions
- What did United States Antimony Corporation file recently?
- 34 SEC filings in the last 12 months. Latest: 8-K on 2026-10-02 — United States Antimony Corporation appointed Shawn P. Winkler as permanent CFO effective September 30, 2026, replacing Richard R. Isaak who was terminated without cause; Winkler has investment banking and CFO experience.
Every figure on this page comes from United States Antimony Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.